Muscular dystrophies (MDs) are a heterogeneous group of inherited disorders, in which progressive muscle wasting and weakness is often associated with exhaustion of muscle regeneration potential. Although physiological properties of skeletal muscle tissue are now well known, no treatments are effective for these diseases. Muscle regeneration was attempted by means transplantation of myogenic cells (from myoblast to embryonic stem cells) and also by interfering with the malignant processes that originate in pathological tissues, such as uncontrolled fibrosis and inflammation. Taking into account the advances in the isolation of new subpopulation of stem cells and in the creation of artificial stem cell niches, we discuss how these emerging technologies offer great promises for therapeutic approaches to muscle diseases and muscle wasting associated with aging.
|Titolo:||Advancements in stem cells treatment of skeletal muscle wasting|
|Parole Chiave:||muscle wasting; stem cell niche; fibrosis; inflammation; myogenic stem cell|
|Settore Scientifico Disciplinare:||Settore MED/26 - Neurologia|
|Data di pubblicazione:||12-feb-2014|
|Digital Object Identifier (DOI):||10.3389/fphys.2014.00048|
|Appare nelle tipologie:||01 - Articolo su periodico|